Apoptosis(凋亡)
As one of the cellular death mechanisms, apoptosis, also known as programmed cell death, can be defined as the process of a proper death of any cell under certain or necessary conditions. Apoptosis is controlled by the interactions between several molecules and responsible for the elimination of unwanted cells from the body.
Many biochemical events and a series of morphological changes occur at the early stage and increasingly continue till the end of apoptosis process. Morphological event cascade including cytoplasmic filament aggregation, nuclear condensation, cellular fragmentation, and plasma membrane blebbing finally results in the formation of apoptotic bodies. Several biochemical changes such as protein modifications/degradations, DNA and chromatin deteriorations, and synthesis of cell surface markers form morphological process during apoptosis.
Apoptosis can be stimulated by two different pathways: (1) intrinsic pathway (or mitochondria pathway) that mainly occurs via release of cytochrome c from the mitochondria and (2) extrinsic pathway when Fas death receptor is activated by a signal coming from the outside of the cell.
Different gene families such as caspases, inhibitor of apoptosis proteins, B cell lymphoma (Bcl)-2 family, tumor necrosis factor (TNF) receptor gene superfamily, or p53 gene are involved and/or collaborate in the process of apoptosis.
Caspase family comprises conserved cysteine aspartic-specific proteases, and members of caspase family are considerably crucial in the regulation of apoptosis. There are 14 different caspases in mammals, and they are basically classified as the initiators including caspase-2, -8, -9, and -10; and the effectors including caspase-3, -6, -7, and -14; and also the cytokine activators including caspase-1, -4, -5, -11, -12, and -13. In vertebrates, caspase-dependent apoptosis occurs through two main interconnected pathways which are intrinsic and extrinsic pathways. The intrinsic or mitochondrial apoptosis pathway can be activated through various cellular stresses that lead to cytochrome c release from the mitochondria and the formation of the apoptosome, comprised of APAF1, cytochrome c, ATP, and caspase-9, resulting in the activation of caspase-9. Active caspase-9 then initiates apoptosis by cleaving and thereby activating executioner caspases. The extrinsic apoptosis pathway is activated through the binding of a ligand to a death receptor, which in turn leads, with the help of the adapter proteins (FADD/TRADD), to recruitment, dimerization, and activation of caspase-8 (or 10). Active caspase-8 (or 10) then either initiates apoptosis directly by cleaving and thereby activating executioner caspase (-3, -6, -7), or activates the intrinsic apoptotic pathway through cleavage of BID to induce efficient cell death. In a heat shock-induced death, caspase-2 induces apoptosis via cleavage of Bid.
Bcl-2 family members are divided into three subfamilies including (i) pro-survival subfamily members (Bcl-2, Bcl-xl, Bcl-W, MCL1, and BFL1/A1), (ii) BH3-only subfamily members (Bad, Bim, Noxa, and Puma9), and (iii) pro-apoptotic mediator subfamily members (Bax and Bak). Following activation of the intrinsic pathway by cellular stress, pro‑apoptotic BCL‑2 homology 3 (BH3)‑only proteins inhibit the anti‑apoptotic proteins Bcl‑2, Bcl-xl, Bcl‑W and MCL1. The subsequent activation and oligomerization of the Bak and Bax result in mitochondrial outer membrane permeabilization (MOMP). This results in the release of cytochrome c and SMAC from the mitochondria. Cytochrome c forms a complex with caspase-9 and APAF1, which leads to the activation of caspase-9. Caspase-9 then activates caspase-3 and caspase-7, resulting in cell death. Inhibition of this process by anti‑apoptotic Bcl‑2 proteins occurs via sequestration of pro‑apoptotic proteins through binding to their BH3 motifs.
One of the most important ways of triggering apoptosis is mediated through death receptors (DRs), which are classified in TNF superfamily. There exist six DRs: DR1 (also called TNFR1); DR2 (also called Fas); DR3, to which VEGI binds; DR4 and DR5, to which TRAIL binds; and DR6, no ligand has yet been identified that binds to DR6. The induction of apoptosis by TNF ligands is initiated by binding to their specific DRs, such as TNFα/TNFR1, FasL /Fas (CD95, DR2), TRAIL (Apo2L)/DR4 (TRAIL-R1) or DR5 (TRAIL-R2). When TNF-α binds to TNFR1, it recruits a protein called TNFR-associated death domain (TRADD) through its death domain (DD). TRADD then recruits a protein called Fas-associated protein with death domain (FADD), which then sequentially activates caspase-8 and caspase-3, and thus apoptosis. Alternatively, TNF-α can activate mitochondria to sequentially release ROS, cytochrome c, and Bax, leading to activation of caspase-9 and caspase-3 and thus apoptosis. Some of the miRNAs can inhibit apoptosis by targeting the death-receptor pathway including miR-21, miR-24, and miR-200c.
p53 has the ability to activate intrinsic and extrinsic pathways of apoptosis by inducing transcription of several proteins like Puma, Bid, Bax, TRAIL-R2, and CD95.
Some inhibitors of apoptosis proteins (IAPs) can inhibit apoptosis indirectly (such as cIAP1/BIRC2, cIAP2/BIRC3) or inhibit caspase directly, such as XIAP/BIRC4 (inhibits caspase-3, -7, -9), and Bruce/BIRC6 (inhibits caspase-3, -6, -7, -8, -9).
Any alterations or abnormalities occurring in apoptotic processes contribute to development of human diseases and malignancies especially cancer.
References:
1.Yağmur Kiraz, Aysun Adan, Melis Kartal Yandim, et al. Major apoptotic mechanisms and genes involved in apoptosis[J]. Tumor Biology, 2016, 37(7):8471.
2.Aggarwal B B, Gupta S C, Kim J H. Historical perspectives on tumor necrosis factor and its superfamily: 25 years later, a golden journey.[J]. Blood, 2012, 119(3):651.
3.Ashkenazi A, Fairbrother W J, Leverson J D, et al. From basic apoptosis discoveries to advanced selective BCL-2 family inhibitors[J]. Nature Reviews Drug Discovery, 2017.
4.McIlwain D R, Berger T, Mak T W. Caspase functions in cell death and disease[J]. Cold Spring Harbor perspectives in biology, 2013, 5(4): a008656.
5.Ola M S, Nawaz M, Ahsan H. Role of Bcl-2 family proteins and caspases in the regulation of apoptosis[J]. Molecular and cellular biochemistry, 2011, 351(1-2): 41-58.
Products for Apoptosis
- Caspase(97)
- 14.3.3 Proteins(1)
- Apoptosis Inducers(43)
- Bax(7)
- Bcl-2 Family(120)
- Bcl-xL(8)
- c-RET(9)
- IAP(27)
- KEAP1-Nrf2(66)
- MDM2(12)
- p53(122)
- PC-PLC(4)
- PKD(7)
- RasGAP (Ras- P21)(1)
- Survivin(8)
- Thymidylate Synthase(10)
- TNF-α(145)
- Other Apoptosis(883)
- APC(6)
- PD-1/PD-L1 interaction(90)
- ASK1(3)
- PAR4(2)
- RIP kinase(52)
- FKBP(20)
- Pyroptosis(30)
- Cat.No. 产品名称 Information
-
GC14203
Citric acid
柠檬酸
柠檬酸是一种天然防腐剂和食品酸味增强剂。
-
GC13292
EGTA
乙二醇双(2-氨基乙基醚)四乙酸
A chelating agent
-
GC16795
DCA
二氯乙酸钠
DCA 是癌细胞中的代谢调节剂';具有抗癌活性的线粒体。 DCA 抑制 PDHK,导致肿瘤微环境中的乳酸减少。 DCA 增加活性氧 (ROS) 生成并促进癌细胞凋亡。 DCA 也可作为 NKCC 抑制剂。
-
GC12090
Nonactin
无活菌素; Ammonium ionophore I
Nonactin是一种大环四内酯类抗生素和线粒体氧化磷酸化解偶联剂。
-
GC15446
Ionomycin free acid
离子霉素,SQ23377
Ionomycin free acid 是一种选择性的强效钙离子载体,可作为活性 Ca2+ 载体。
-
GC15211
Damnacanthal
Damnacanthal 是一种从海巴戟根中分离出来的蒽醌。
-
GC16673
N-Formyl-Met-Leu-Phe
酪胺盐酸盐,fMLP; N-Formyl-MLF
N-Formyl-Met-Leu-Phe是一种内源性趋化肽,也是甲酰肽受体1(FPR1)的激动剂,Ki值为38 nM。
-
GC17346
KT 5823
蛋白激酶仰制剂KT5823
Potent selective inhibitor of cGMP-dependent protein kinase (PKG)
-
GC11200
A23187
离子载体(钙镁盐混合物),Calcimycin
A23187自由酸是一种Ca2+离子载体。
-
GC11482
Thapsigargin
毒胡萝卜素
他普西加林是一种肌浆网/内质网Ca2+ ATP酶泵的抑制剂。
-
GC14533
Kynurenic acid
犬尿喹啉酸; Quinurenic acid
Kynurenic acid 是一种内源性色氨酸代谢物,是一种针对 NMDA、谷氨酸、α7 烟碱乙酰胆碱受体的广谱拮抗剂。
-
GC12718
Pantoprazole
泮托拉唑; BY1023; SKF96022
A proton pump inhibitor
-
GC12647
NVP-CGM097
CGM097
An inhibitor of the MDM2-p53 interaction
-
GC12333
BV6
A bivalent Smac mimetic and IAP antagonist
-
GC15586
AP1903
AP1903
AP1903是一种二价"二聚化"化合物,可与FKBP结合并诱导Fas交联。
-
GC12515
NMS-1286937
4,5-二氢-1-(2-羟基乙基)-8-[[5-(4-甲基-1-哌嗪基)-2-(三氟甲氧基)苯基]氨基]-1H-吡唑并[4,3-H]喹唑啉-3-甲酰胺,NMS-1286937; NMS-P937
NMS-1286937是一种口服有效的小分子化合物,能够高效且选择性地抑制Polo样激酶1(PLK1)的活性,半数抑制浓度(IC50)为2nM。
-
GC10083
MPI-0479605
A potent inhibitor of MPS1
-
GC15462
ISRIB (trans-isomer)
ISRIB(TRANS-ISOMER)抑制剂
ISRIB (trans-isomer)是一种选择性抑制整合应激反应(ISR)通路的小分子化合物。ISRIB (trans-isomer)是PERK的一种高度选择性抑制剂,IC50为5nM。
-
GC10468
4EGI-1
eIF4E/eIF4G Interaction Inhibitor
An inhibitor of mRNA translation
-
GC13484
Griseofulvin
灰黄霉素
A fungal metabolite with antifungal and anticancer activities
-
GC16237
Apocynin
香草乙酮; Acetovanillone
Apocynin是一种天然存在的苯乙酮类化合物,可作为NADPH氧化酶复合物的强效抑制剂,IC50值为10μM。
-
GC12975
Indirubin
靛玉红; Couroupitine B; Indigo red; Indigopurpurin
Indirubin是强效的周期蛋白依赖性激酶(CDKs)(IC50:50-100nmol/L)和糖原合成酶激酶-3β(GSK-3β)(IC50:5-50nmol/L)抑制剂,具有口服给药特性。
-
GC14800
ML 141
CID-2950007
An allosteric Cdc42 inhibitor
-
GC17960
U 73343
U 73343是U 73122的非活性类似物。
-
GC12411
RHC 80267
1,6-双(环己基脒基羰基氨基)己烷,U-57908
RHC 80267是一种有效的、选择性二酰基甘油脂酶(DAGL)抑制剂,RHC 80267还能够抑制胆碱酯酶活性(IC₅₀=4μM),可抑制环氧化酶(COX)活性和磷脂酰胆碱的水解。
-
GC10501
VER-50589
Inhibitor of Hsp90
-
GC16922
Kobe0065
A selective Ras inhibitor
-
GC18133
ATB-346
ATB-346
An H2S-releasing NSAID
-
GC17995
Tacrolimus monohydrate
他克莫司一水合物; FK506 monohydrate; Fujimycin monohydrate; FR900506 monohydrate
他克莫司一水合物 (FK506 monohydrate) 是一种大环内酯,与 FK506 结合蛋白 (FKBP) 结合形成复合物并抑制钙调神经磷酸酶,从而抑制 T 淋巴细胞信号转导和 IL-2 转录。
-
GC13693
Omaveloxolone (RTA-408)
RTA 408
Omaveloxolone (RTA-408)是一种抗氧化炎症调节剂(AIM),可激活Nrf2并抑制一氧化氮(NO)的生成。
-
GC15670
Rabeprazole sodium
雷贝拉唑钠; LY307640 sodium
A proton pump inhibitor
-
GC10451
U-73122
1-[6-[((17Β)-3-雌酮-1,3,5[10]-三烯-17-基)氨基]乙基]-1H-吡咯-2,5-二酮
U-73122是有效的、选择性的磷脂酶C(PLC)抑制剂,IC50值约为1-2.1µM,也可抑制5-脂氧合酶(5-LO)。
-
GC16843
Hydroxyurea
羟基脲; Hydroxycarbamide
An antineoplastic agent
-
GC15775
Metronidazole
甲硝唑
An antibiotic
-
GC12051
Amiloride HCl dihydrate
盐酸阿米洛利二水合物; MK-870 hydrochloride dihydrate
An Analytical Reference Standard
-
GC12256
D-Mannitol
D-甘露醇 ; Mannitol; Mannite
An Analytical Reference Standard
-
GC15857
Sodium butyrate
丁酸钠
A short-chain fatty acid and HDAC inhibitor
-
GC12318
Candesartan Cilexetil
坎地沙坦酯; TCV-116
A prodrug form of candesartan
-
GC11655
Moexipril HCl
莫昔普利盐酸盐,RS-10085
A prodrug form of moexiprilat
-
GC15550
Lacidipine
拉西地平
An L-type calcium channel blocker
-
GC17750
Raltitrexed
雷替曲塞; ZD1694; D1694; ICI-D1694
An inhibitor of thymidylate synthase
-
GC12105
Etidronate
羟基乙叉二膦酸,Etidronate; HEDPA; HEDP
A bisphosphonate bone resorption inhibitor
-
GC17121
Mycophenolic acid
霉酚酸; Mycophenolate
An immunosuppressive microbial metabolite
-
GC13210
Flubendazole
氟苯咪唑
An anthelmintic
-
GC11670
Pranoprofen
普拉洛芬
An NSAID and COX-1 inhibitor
-
GC11532
Lonidamine
氯尼达明; AF-1890; Diclondazolic Acid; DICA
Lonidamine是一种己糖激酶、线粒体丙酮酸载体(在分离的大鼠肝脏线粒体中Ki为2.5μM)和质膜单羧酸转运蛋白抑制剂,同时还抑制线粒体复合物 II。
-
GC12066
Retinyl (Vitamin A) Palmitate
维生素A棕榈酸酯
A natural form of vitamin A
-
GC15271
Tyrphostin AG 879
AG 879
A non-specific tyrphostin ErbB2 inhibitor
-
GC14273
TTNPB (Arotinoid Acid)
Ro 13-7410; Arotinoid acid; AGN191183
A potent, selective RAR agonist
-
GC10469
Sulfamethoxypyridazine
磺胺甲氧哒嗪
A sulfonamide antibiotic